Psychopharmacology SCIE

國(guó)際簡(jiǎn)稱：PSYCHOPHARMACOLOGY 參考譯名：精神藥理學(xué)

主要研究方向：醫(yī)學(xué)-精神病學(xué) 非預(yù)警期刊審稿周期：較快,2-4周

《精神藥理學(xué)》(Psychopharmacology)是一本由Springer Berlin Heidelberg出版的以醫(yī)學(xué)-精神病學(xué)為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
201 年發(fā)文量
3.5 IF影響因子
未開放 是否OA
181 H-index
1959 創(chuàng)刊年份
Semimonthly 出版周期
English 出版語言

Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

[ 查看全部 ]

投稿咨詢加急咨詢

Psychopharmacology期刊信息

ISSN：0033-3158
出版語言：English
是否OA：未開放
E-ISSN：1432-2072
出版地區(qū)：GERMANY
是否預(yù)警：否
出版商：Springer Berlin Heidelberg
出版周期：Semimonthly
創(chuàng)刊時(shí)間：1959
開源占比：0.2166
Gold OA文章占比：29.69%
OA被引用占比：0.3149...
出版國(guó)人文章占比：0.07
出版撤稿占比：0
研究類文章占比：91.04%

Psychopharmacology CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.1

1.053

0.861

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmacology	Q2	88 / 313	72%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Psychopharmacology中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	NEUROSCIENCES 神經(jīng)科學(xué) PHARMACOLOGY & PHARMACY 藥學(xué) PSYCHIATRY 精神病學(xué)	3區(qū) 3區(qū) 3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	NEUROSCIENCES 神經(jīng)科學(xué) PHARMACOLOGY & PHARMACY 藥學(xué) PSYCHIATRY 精神病學(xué)	3區(qū) 3區(qū) 3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué) NEUROSCIENCES 神經(jīng)科學(xué) PSYCHIATRY 精神病學(xué)	2區(qū) 3區(qū) 3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	NEUROSCIENCES 神經(jīng)科學(xué) PHARMACOLOGY & PHARMACY 藥學(xué) PSYCHIATRY 精神病學(xué)	3區(qū) 3區(qū) 3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué) NEUROSCIENCES 神經(jīng)科學(xué) PSYCHIATRY 精神病學(xué)	2區(qū) 3區(qū) 3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	NEUROSCIENCES 神經(jīng)科學(xué) PHARMACOLOGY & PHARMACY 藥學(xué) PSYCHIATRY 精神病學(xué)	3區(qū) 3區(qū) 3區(qū)

Psychopharmacology JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：NEUROSCIENCES	SCIE	Q2	109 / 310	65%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	100 / 354	71.9%
學(xué)科：PSYCHIATRY	SCIE	Q2	75 / 276	73%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：NEUROSCIENCES	SCIE	Q2	109 / 310	65%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	97 / 354	72.74%
學(xué)科：PSYCHIATRY	SCIE	Q2	85 / 276	69.38%

Psychopharmacology歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Psychopharmacology中國(guó)學(xué)者發(fā)文選摘

1、Desulfovibrio confers resilience to the comorbidity of pain and anxiety in a mouse model of chronic inflammatory pain
Author: Wu, Zifeng; Liu, Hanyu; Yan, Enshi; Zhang, Xinying; Wang, Yuanyuan; Huang, Chaoli; He, Teng; Miao, Liying; Yang, Ling; Jiang, Riyue; Qi, Changyong; Liu, Cunming; Wang, Di; Yang, Chun

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 1, pp. 87-100. DOI: 10.1007/s00213-022-06277-4
2、The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex
Author: Tang, Zi-Hang; Yu, Zhi-Peng; Li, Qiong; Zhang, Xiao-Qin; Muhetaer, Kadeliya; Wang, Zheng-Chun; Xu, Peng; Shen, Hao-Wei

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00213-023-06366-y
3、The M1 muscarinic acetylcholine receptor regulates the surface expression of the AMPA receptor subunit GluA2 via PICK1
Author: Zhu, Zengyan; Wang, Wenjuan; Gu, Chao; Wang, Mei; Yan, Yinghui

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 1, pp. 239-248. DOI: 10.1007/s00213-022-06304-4
4、Chronic restraint stress-induced depression-like behavior is mediated by upregulation of melanopsin expression in C57BL/6 mice retina
Author: Fu, Yingmei; Liu, Shanshan; Dong, Yigang; Gan, Yixia; Guo, Xiaoyun; Liu, Hongmei; Xu, Qingqing; Yuan, Ruixue; Ning, Ailing; Hong, Wu; Peng, Yanmin; Yu, Shunying

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 2, pp. 283-293. DOI: 10.1007/s00213-022-06302-6
5、Melatonin alleviates PTSD-like behaviors and restores serum GABA and cortisol levels in mice
Author: Xu, Zixuan; Li, Wen; Sun, Yixin; Jin, Wen; Yu, Li; Yang, Jingyuan; Wang, Qi

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 2, pp. 259-269. DOI: 10.1007/s00213-023-06312-y
6、The interaction between first-episode drug-naive schizophrenia and age based on gray matter volume and its molecular analysis: a multimodal magnetic resonance imaging study
Author: Chen, Jingli; Wei, Yarui; Xue, Kangkang; Han, Shaoqiang; Wang, Caihong; Wen, Baohong; Cheng, Jingliang

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 813-826. DOI: 10.1007/s00213-023-06323-9
7、Inhibition of mGluR5 alters BDNF/TrkB and GLT-1 expression in the prefrontal cortex and hippocampus and ameliorates PTSD-like behavior in rats
Author: Cheng, Shuyue; Xu, Jingjing; Wang, Wei; Wang, Rui; Li, Haonan; Jiang, Zhijun; Liu, Dexiang; Pan, Fang

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 837-851. DOI: 10.1007/s00213-023-06325-7
8、Flupirtine and antihistamines exert synergistic anti-nociceptive effects in mice
Author: Chen, Yanming; Xiao, Xinyi; Huang, Chaonan; Zhu, Jin; Zhou, Huiling; Qin, Huimin; Bao, Yu; Zhuang, Tao; Zhang, Guisen

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 881-897. DOI: 10.1007/s00213-023-06329-3